Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.

Nausch N, Florin L, Hartenstein B, Angel P, Schorpp-Kistner M, Cerwenka A.

J Immunol. 2006 Jan 1;176(1):7-11.

2.

Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.

Hayakawa Y, Kelly JM, Westwood JA, Darcy PK, Diefenbach A, Raulet D, Smyth MJ.

J Immunol. 2002 Nov 15;169(10):5377-81.

3.

T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.

Teng MW, Kershaw MH, Hayakawa Y, Cerutti L, Jane SM, Darcy PK, Smyth MJ.

J Biol Chem. 2005 Nov 18;280(46):38235-41. Epub 2005 Sep 16.

4.

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.

André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P.

Eur J Immunol. 2004 Apr;34(4):961-71.

6.

Activation of V gamma 9V delta 2 T cells by NKG2D.

Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T.

J Immunol. 2005 Aug 15;175(4):2144-51.

7.
8.

Construction of a plasmid for co-expression of mouse membrane-bound form of IL-15 and RAE-1ε and its biological activity.

Qian L, Ji MC, Pan XY, Gong WJ, Tian F, Duan QF.

Plasmid. 2011 May;65(3):239-45. doi: 10.1016/j.plasmid.2011.02.004. Epub 2011 Mar 4.

PMID:
21377489
9.

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T.

Science. 1999 Jul 30;285(5428):727-9.

10.

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.

Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.

Eur J Immunol. 2003 Feb;33(2):381-91.

11.
12.

Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells.

Nausch N, Galani IE, Schlecker E, Cerwenka A.

Blood. 2008 Nov 15;112(10):4080-9. doi: 10.1182/blood-2008-03-143776. Epub 2008 Aug 27.

13.

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.

Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, Vivier E, Held W.

Blood. 2005 Sep 1;106(5):1711-7. Epub 2005 May 10.

14.

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.

Wiemann K, Mittrücker HW, Feger U, Welte SA, Yokoyama WM, Spies T, Rammensee HG, Steinle A.

J Immunol. 2005 Jul 15;175(2):720-9.

15.

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR.

J Immunol. 2008 Nov 15;181(10):6711-9.

16.

Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.

Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW Jr, Chatterjee SK.

J Immunol. 2005 Oct 15;175(8):5541-50.

17.

Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions.

Backström E, Chambers BJ, Ho EL, Naidenko OV, Mariotti R, Fremont DH, Yokoyama WM, Kristensson K, Ljunggren HG.

Eur J Immunol. 2003 Jan;33(1):92-100.

18.
19.

IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.

Vahlne G, Becker S, Brodin P, Johansson MH.

Scand J Immunol. 2008 Jan;67(1):1-11. Epub 2007 Nov 19.

20.

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH.

Nat Immunol. 2000 Aug;1(2):119-26.

PMID:
11248803

Supplemental Content

Support Center